Jarvis Scot B sells Kratos (KTOS) shares worth $390,700

Director Jarvis Scot B sold 5,000 Kratos shares on March 26, 2026 for $78.14 each, totaling $390,700 under a pre-arranged 10b5-1 plan, leaving him with 80,417 shares. Kratos won a $49.2M Naval Surface Warfare Center contract for Oriole solid rocket motors and thrust-vector-control nozzle kits and secured a SKY Perfect JSAT contract to develop a 5G Non-Terrestrial Network ground system for APAC. The company is progressing on an uncrewed combat aircraft program with Airbus (maiden flight planned this year) and led a $190M Rocket Lab hypersonic test-flight contract (Rocket Lab’s largest single launch deal). David King was also added to Kratos’s board to the Audit Committee, underscoring incremental governance and contract momentum.

Analysis

Mid-tier aerospace/defense firms that own specialized manufacturing (solid rocket motors, thrust-vector kits, uncrewed aircraft integration) are positioned to capture disproportionate margin upside if they can scale capacity quickly; conversely, large primes that rely on broad systems integration will be slower to re-price for these niche, high-growth streams. Supply-chain knock-on effects are non-linear: a single supplier bottleneck in carbon composites or high-temperature alloys can shift margin mix by 300–700bps and delay revenue recognition by 6–18 months, amplifying execution risk for companies with aggressive backlog-to-revenue assumptions.

The most actionable catalysts crystallize on two timelines: near-term (0–6 months) technical milestones that de-risk systems integration and trigger milestone payments, and medium-term (6–36 months) manufacturing ramp metrics that convert awarded value into free cash flow. Tail risks include budget reallocations, export-control friction that constrains European market scale-up, or a single high-profile test failure that could cut implied probability of follow-on orders by half; each of these can flip consensus upside into a >20% drawdown within a quarter.

Consensus appears to underweight the capital intensity of converting wins into sustainable EBITDA — investors are pricing awards as high-probability revenue without fully modeling 12–24 month working-capital and CapEx needs. That asymmetry creates a skew where successful technical milestones could produce 30–60% upside over 6–18 months, while execution disappointment or macro budget shifts can produce 20–40% downside in a single quarter. Hedged, milestone-driven exposures maximize asymmetric return while limiting binary program risk.

Key Decisions for Investors

• Long KTOS (6–12 months): buy shares or a call-spread to capture milestone re-rating — target +35–45% if technical/contract milestones hit and manufacturing scales; size 3–5% portfolio, stop-loss at -15% to limit execution risk.
• Pair trade (6–12 months): long KTOS / short RTX (equal notional) to isolate program-execution vs broad launch exposure — expect asymmetric return if KTOS converts niche systems revenue while RTX reflects macro launch cadence; reduce pair if sector funding or launch schedules shift.
• Long RKLB (3–9 months): buy short-dated calls or long shares to capture accelerated launch demand tied to hypersonic and dedicated-test flights — target +40% if cadence holds, cut to breakeven on a missed launch or schedule slip greater than 30 days.
• Protective hedge (0–6 months): buy 3–6 month puts or collars on KTOS sized to 30–50% of long position to guard against a binary test failure or abrupt defense budget reprioritization; cost is justified given single-event downside can exceed 20–30%.